Dextenza Insert and Tofacitinib Extended-Release Tablets
Determining the interaction of Dextenza Insert and Tofacitinib Extended-Release Tablets and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: dexamethasone ophthalmic
Brand name: Dextenza, Dexycu, Ozurdex, Maxidex
Synonyms: Dextenza (intraocular)
Generic Name: tofacitinib
Brand name: Xeljanz, Xeljanz XR
Synonyms: Tofacitinib
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Dextenza Insert-Tofacitinib Tablets
- Dextenza Insert-Tofranil
- Dextenza Insert-Tofranil injection
- Dextenza Insert-Tofranil-PM
- Dextenza Insert-Tol-Tab
- Dextenza Insert-Tolazamide
- Tofacitinib Extended-Release Tablets-Dextenza intraocular
- Tofacitinib Extended-Release Tablets-Dextran 40
- Tofacitinib Extended-Release Tablets-Dextran 70 6% in 5% Dextrose high molecular weight
- Tofacitinib Extended-Release Tablets-Dextran 75
- Tofacitinib Extended-Release Tablets-Dextran high molecular weight
- Tofacitinib Extended-Release Tablets-Dextranomer and Hyaluronate Derivatives (Deflux)